Galectin-9 in physiological and pathological conditions

被引:163
|
作者
Hirashima, M
Kashio, Y
Nishi, N
Yamauchi, A
Imaizumi, T
Kageshita, T
Saita, N
Nakamura, T
机构
[1] Kagawa Med Univ, Dept Immunol & Immunopathol, Miki, Kagawa 7610793, Japan
[2] Kagawa Med Univ, Dept Endocrinol, Miki, Kagawa 7610793, Japan
[3] Kagawa Med Univ, Dept Surg, Miki, Kagawa 7610793, Japan
[4] Hirosaki Univ, Sch Med, Inst brain Sci, Dept Vasc Biol, Hirosaki, Aomori 036, Japan
[5] Kumamoto Univ, Sch Med, Dept Dermatol, Kumamoto 860, Japan
[6] Kumamoto Univ, Sch Med, Dept Internal Med, Kumamoto 860, Japan
关键词
galectin-9 (Gal-9); eosinophil activation; cancer; apoptosis; prognosis;
D O I
10.1023/B:GLYC.0000014090.63206.2f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We first cloned galectin-9 (Gal-9)/ecalectin as a T cell-derived eosinophil chemoattractant. Gal-9 plays a role in not only accumulation but also activation of eosinophils in experimental allergic models and human allergic patients, because Gal-9 induces eosinophil chemoattraction in vitro and in vivo and activates eosinophils in many aspects. Gal-9 requires divalent galactoside-binding activity but not the linker peptide of Gal-9 to exhibit its biological functions, and an unidentified matrix metalloproteinase is involved in the release of Gal-9. Our recent studies also showed that Gal-9 has other functions, such as cell differentiation, aggregation, adhesion, and death. Now, we and other groups are on the way of investigating the regulation and function of Gal-9 in a variety of physiological and pathological conditions. In this article, we will show the possible role of Gal-9 in physiological and pathological conditions by using our recent findings.
引用
收藏
页码:593 / 600
页数:8
相关论文
共 50 条
  • [31] Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells
    Akashi, Emiko
    Fujihara, Shintaro
    Morishita, Asahiro
    Tadokoro, Tomoko
    Chiyo, Taiga
    Fujikawa, Keiko
    Kobara, Hideki
    Mori, Hirohito
    Iwama, Hisakazu
    Okano, Keiichi
    Suzuki, Yasuyuki
    Niki, Toshiro
    Hirashima, Mitsuomi
    Masaki, Tsutomu
    ONCOLOGY REPORTS, 2017, 38 (01) : 506 - 514
  • [32] Novel role for galectin-1 in T-cells under physiological and pathological conditions
    Deak, Magdolna
    Hornung, Akos
    Novak, Julianna
    Demydenko, Dmytro
    Szabo, Eniko
    Czibula, Agnes
    Fajka-Boja, Roberta
    Kriston-Pal, Eva
    Monostori, Eva
    Kovacs, Laszlo
    IMMUNOBIOLOGY, 2015, 220 (04) : 483 - 489
  • [33] Galectin-9 in Allergic Airway Inflammation and Hyper-Responsiveness in Mice
    Sziksz, Erna
    Kozma, Gergely Tibor
    Pallinger, Eva
    Komlosi, Zsolt Istvan
    Adori, Csaba
    Kovacs, Lajos
    Szebeni, Beata
    Rusai, Krisztina
    Losonczy, Gyoergy
    Szabo, Andras
    Vannay, Adam
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2010, 151 (04) : 308 - 317
  • [34] Galectin-9 suppresses the tumor growth of colon cancer in vitro and in vivo
    Morishita, Asahiro
    Nomura, Kei
    Tani, Joji
    Fujita, Koji
    Iwama, Hisakazu
    Takuma, Kei
    Nakahara, Mai
    Tadokoro, Tomoko
    Oura, Kyoko
    Chiyo, Taiga
    Fujihara, Shintaro
    Niki, Toshiro
    Hirashima, Mitsuomi
    Nishiyama, Akira
    Himoto, Takashi
    Masaki, Tsutomu
    ONCOLOGY REPORTS, 2021, 45 (06)
  • [35] The protective function of galectin-9 in liver ischemia and reperfusion injury in mice
    Hirao, Hirofumi
    Uchida, Yoichiro
    Kadono, Kentaro
    Tanaka, Hirokazu
    Niki, Toshiro
    Yamauchi, Akira
    Hata, Koichiro
    Watanabe, Takeshi
    Terajima, Hiroaki
    Uemoto, Shinji
    LIVER TRANSPLANTATION, 2015, 21 (07) : 969 - 981
  • [36] Galectin-9 as a new biomarker of acute-on-chronic liver failure
    Ling, Jun
    You, Shaoli
    Chen, Weiwei
    Yang, Xinxin
    Xv, Yiwen
    Zhu, Bing
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [37] A Possible Role of Galectin-9 in the Pulmonary Fibrosis of Patients with Interstitial Pneumonia
    Matsumoto, Nobuhiro
    Katoh, Shigeki
    Yanagi, Shigehisa
    Arimura, Yasuji
    Tokojima, Masatoshi
    Ueno, Masaki
    Hirashima, Mitsuomi
    Nakazato, Masamitsu
    LUNG, 2013, 191 (02) : 191 - 198
  • [38] Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma
    Fu, Hangcheng
    Liu, Yidong
    Xu, Le
    Liu, Weisi
    Fu, Qiang
    Liu, Haiou
    Zhang, Weijuan
    Xu, Jiejie
    TUMOR BIOLOGY, 2015, 36 (08) : 5791 - 5799
  • [39] Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
    Lee, Byung-Hyun
    Park, Yong
    Kim, JI-Hea
    Kang, Ka-Won
    Lee, Seung-Jin
    Kim, Seok Jin
    Kim, Byung Soo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] Serum level of galectin-9 as a potential biomarker for high risk of malignancy in dermatomyositis
    Shih, Yanting
    Chen, Shile
    Huang, Jie
    Chen, Yongheng
    Zhu, Zicong
    Zhao, Qian
    Zhao, Xiaoqing
    Xue, Feng
    Xiang, Jie
    Chen, Xiaosong
    Zhu, Xuemei
    Pan, Meng
    Wu, Jun
    Zheng, Jie
    Li, Hao
    Cao, Hua
    RHEUMATOLOGY, 2024, 63 (01) : 251 - 258